我们是否越来越接近成功的新抗原癌症疫苗?
Karen Manoutcharian1, Goar Gevorkian1
1Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM), CDMX, Apartado Postal 70228, Cuidad Universitaria, Mexico DF, CP, 04510, Mexico.
Molecular aspects of medicine
|February 14, 2024
概括
癌症疫苗治疗显示出希望,但面临着巨大的障碍,如瘤免疫抑制和新抗原的演变. 克服这些挑战需要对下一代癌症疫苗采取创新,非传统的方法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 癌症免疫疗法已经取得了重大进展,但癌症疫苗治疗需要更多的疗效数据才能获得监管部门的批准.
- 尽管进行了数十年的研究,但癌症疫苗仍面临着持续的挑战,影响其开发和临床成功.
研究的目的:
- 审查阻碍癌症疫苗开发的关键挑战.
- 讨论当前以新抗原为重点的策略,并强调需要使用替代疫苗方法.
主要方法:
- 关于癌症疫苗开发现有挑战的文献综述.
- 对当前基于新抗原的策略及其局限性的分析.
- 探索潜在的替代疫苗概念.
主要成果:
- 确定了主要障碍,包括瘤诱导的免疫抑制,抑制性瘤微环境 (TME),瘤内异质性 (ITH) 和动态新抗原景观.
- 突出了一些鲜为人知的问题,如新抗原动力学,T细胞反应时间和免疫干扰.
- 目前的新抗原方法由于瘤进化和免疫相互作用的复杂性而面临局限性.
结论:
- 显著的挑战阻碍了当前癌症疫苗的有效性.
- 对于推进癌症疫苗开发的新"开箱即用"策略,有极大需要.
- 未来的研究应该专注于非传统的思维,以克服现有的障碍,并创造下一代癌症治疗方法.
更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.8K
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
相关概念视频
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
